Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Net Cash Flow (2019 - 2025)

AVITA Medical filings provide 7 years of Net Cash Flow readings, the most recent being -$5.2 million for Q4 2025.

  • On a quarterly basis, Net Cash Flow fell 12.86% to -$5.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$3.8 million, a 52.81% increase, with the full-year FY2025 number at -$3.8 million, up 52.81% from a year prior.
  • Net Cash Flow hit -$5.2 million in Q4 2025 for AVITA Medical, down from $3.2 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $55.1 million in Q1 2021 to a low of -$64.0 million in Q2 2022.
  • Median Net Cash Flow over the past 5 years was -$3.6 million (2024), compared with a mean of -$7.3 million.
  • Biggest five-year swings in Net Cash Flow: soared 822.38% in 2021 and later tumbled 629.74% in 2025.
  • AVITA Medical's Net Cash Flow stood at -$50.2 million in 2021, then soared by 88.66% to -$5.7 million in 2022, then crashed by 404.57% to -$28.7 million in 2023, then surged by 84.03% to -$4.6 million in 2024, then fell by 12.86% to -$5.2 million in 2025.
  • The last three reported values for Net Cash Flow were -$5.2 million (Q4 2025), $3.2 million (Q3 2025), and -$2.7 million (Q2 2025) per Business Quant data.